The relative risk of cholelithiasis was 1.2, 1.3, and 1.4 in liraglutide, dulaglutide, and semaglutide with number needed to harm of 17.25, 14.69, and 10.96, respectively
Treatment starts with 0.25 mg weekly for 4 weeks as an initiation dose only (not for glycaemic maintenance), then increases to 0.5 mg weekly
it is the protocol working as intended
Pinch a fold of skin at your chosen site
phase 2 trial data confirm gastrointestinal side effects are common, though heartburn was not consistently itemised as a standalone adverse event
The band prevents it from rolling in the fridge and ending up against the back wall where freezing can occur